OraSure Technologies, Inc. (NASDAQ:OSUR) SVP Sells $1,525,826.51 in Stock

OraSure Technologies, Inc. (NASDAQ:OSUR) SVP Jack E. Jerrett sold 73,463 shares of the stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $20.77, for a total transaction of $1,525,826.51. Following the completion of the transaction, the senior vice president now directly owns 81,593 shares in the company, valued at $1,694,686.61. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Shares of OraSure Technologies, Inc. (NASDAQ OSUR) traded up 1.23% during trading on Tuesday, hitting $21.46. 1,088,278 shares of the stock traded hands. The stock has a 50 day moving average price of $17.63 and a 200-day moving average price of $13.64. The stock has a market cap of $1.25 billion, a price-to-earnings ratio of 39.67 and a beta of 1.57. OraSure Technologies, Inc. has a 1-year low of $6.84 and a 1-year high of $21.55.

OraSure Technologies (NASDAQ:OSUR) last issued its quarterly earnings data on Wednesday, August 2nd. The medical instruments supplier reported $0.09 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.07 by $0.02. OraSure Technologies had a return on equity of 15.64% and a net margin of 22.29%. The company had revenue of $40.18 million during the quarter, compared to analyst estimates of $36.54 million. During the same quarter in the previous year, the firm earned $0.07 earnings per share. OraSure Technologies’s revenue was up 28.1% on a year-over-year basis. Equities analysts forecast that OraSure Technologies, Inc. will post $0.48 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This article was posted by Markets Daily and is owned by of Markets Daily. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright law. The correct version of this article can be viewed at https://www.themarketsdaily.com/2017/08/08/orasure-technologies-inc-nasdaqosur-svp-sells-1525826-51-in-stock.html.

Several brokerages have recently weighed in on OSUR. Jefferies Group LLC increased their price objective on shares of OraSure Technologies from $12.00 to $16.00 and gave the company a “buy” rating in a research report on Thursday, May 4th. Canaccord Genuity increased their price objective on shares of OraSure Technologies from $21.00 to $22.00 and gave the company a “buy” rating in a research report on Thursday, August 3rd. Zacks Investment Research lowered shares of OraSure Technologies from a “buy” rating to a “hold” rating in a research report on Wednesday, April 12th. BidaskClub lowered shares of OraSure Technologies from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Finally, Stephens reissued an “overweight” rating and issued a $19.00 price objective (up from $14.00) on shares of OraSure Technologies in a research report on Tuesday, July 11th. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $15.46.

Several hedge funds and other institutional investors have recently modified their holdings of OSUR. Alps Advisors Inc. raised its stake in shares of OraSure Technologies by 0.3% in the second quarter. Alps Advisors Inc. now owns 43,257 shares of the medical instruments supplier’s stock valued at $747,000 after buying an additional 111 shares in the last quarter. PNC Financial Services Group Inc. raised its stake in shares of OraSure Technologies by 0.5% in the first quarter. PNC Financial Services Group Inc. now owns 46,588 shares of the medical instruments supplier’s stock valued at $602,000 after buying an additional 242 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of OraSure Technologies by 0.5% in the first quarter. Wellington Management Group LLP now owns 111,970 shares of the medical instruments supplier’s stock valued at $1,448,000 after buying an additional 587 shares in the last quarter. Private Advisor Group LLC raised its stake in shares of OraSure Technologies by 7.1% in the first quarter. Private Advisor Group LLC now owns 10,923 shares of the medical instruments supplier’s stock valued at $135,000 after buying an additional 723 shares in the last quarter. Finally, Arizona State Retirement System raised its stake in shares of OraSure Technologies by 3.4% in the second quarter. Arizona State Retirement System now owns 30,100 shares of the medical instruments supplier’s stock valued at $520,000 after buying an additional 1,000 shares in the last quarter. 90.12% of the stock is owned by institutional investors.

OraSure Technologies Company Profile

OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.

Insider Buying and Selling by Quarter for OraSure Technologies (NASDAQ:OSUR)

Receive News & Ratings for OraSure Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply